CareSpeak, Molina raise medication adherence with texting

Molina Healthcare and CareSpeak Communications launched a text messaging platform to remind patients to take their medication.

Members will be able to receive personalized text reminders on medication therapy management to improve medication adherence, including even the most complex dosing regimens. They will also receive feedback from a pharmacist when their adherence levels fall below a certain level.

“All signs are pointing to mobile health becoming an important tool in the daily life of the chronically ill and their caregiver family members," said Serge Loncar, CEO of CareSpeak. “We are excited to be able to offer our user-friendly and clinically effective solution to Molina and their members.”

Molina will provide CareSpeak’s digital health platform to members in California, Michigan and Ohio, available in both English and Spanish.

“Molina’s mission is to provide quality health services to financially vulnerable families. Our members tend to be at greater risk for prescription medication errors and non-adherence. Digital technologies like the CareSpeak text messaging platform are affordable and scalable tools we can use in combination with our medication therapy management to better help our members manage their medications and avoid the unintended consequences of non-adherence," said Martha Molina Bernadett, MD, Chief Innovation Officer at Molina Healthcare.

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

CMS finalized a significant policy change when it increased the Medicare payments hospitals receive for performing CCTA exams. What, exactly, does the update mean for cardiologists, billing specialists and other hospital employees?

Stryker, a global medtech company based out of Michigan, has kicked off 2025 with a bit of excitement. The company says Inari’s peripheral vascular portfolio is highly complementary to its own neurovascular portfolio.

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.